Selective Inhibition of Osteoclast Vacuolar H+-ATPase

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|23|2033-2048

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.23, 2002-10, pp. : 2033-2048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective inhibitors of vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity

By Farina C.   Gagliardi S.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 157-168

Informa Healthcare

Access to resources Recommend Favorite

Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H+-ATPase as an emerging target

By Kartner Norbert   Manolson Morris F  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 505-522

Informa Healthcare

Access to resources Recommend Favorite

Discovery of steroid glycosides with selective inotropic action using Na+/K+-ATPase isoforms expressed in 'receptor blasts'. Selective inhibition of a1-isoform of Na+/K+-transporting ATPase (Na+/K+-ATPase) in cardiac muscle of man.

By Repke K.   Megges R.   Repke H.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Novel Marine and Microbial Natural Product Inhibitors of Vacuolar ATPase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 9, 2003-05 ,pp. : 787-796

Bentham Science Publishers

Access to resources Recommend Favorite

The putative 116 kDa osteoclast specific vacuolar proton pump subunit has ubiquitous tissue distribution

By Scott B.B.   Chapman C.G.  

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite